Conferences

A prevalence of left atrial fibrosis in endurance athletes could explain their increased risk for arrhythmias like atrial fibrillation (AFib), according to data presented this week at the European Society of Cardiology (ESC) Congress in Munich.

Late-breaking results of a trial presented at the European Society of Cardiology (ESC)’s 2018 meeting in Munich suggest a removable balloon is as effective as a permanent stent in unblocking small arteries. 

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

Preliminary results from a European Society of Cardiology (ESC) poll suggest the best long-term investment medical institutions can make is in their own employees, whose risk for burnout could be mitigated by more dynamic, supportive work environments where they feel valued.

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to run into clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

Major cardiology associations joined forces to define and standardize what exactly constitutes a heart attack, differentiating between myocardial infarction (MI) and “myocardial injury” while offering guidance on how to incorporate emerging imaging techniques and high-sensitivity troponin assays.

Combining oral anticoagulants with antiplatelet therapy in atrial fibrillation (AFib) patients could be more than just overkill, University of Edinburgh researchers reported at the European Society of Cardiology’s annual meeting this month. It could be dangerous, increasing the risk for all-cause death, stroke and major bleeding events in those without an indication for dual treatment.

Despite its relative rarity in clinical practice, the Ross procedure provides a survival benefit over mechanical aortic valve replacement in young and middle-aged patients, suggests a meta-analysis published in JAMA Cardiology and presented at the European Society of Cardiology (ESC) Congress in Munich.

The addition of perivascular fat attenuation to routine coronary computed tomography angiography (CTA) improves risk stratification in heart patients, according to research presented at the European Society of Cardiology (ESC)’s annual symposium in Munich, surpassing current prognostic models to re-classify and predict cardiac deaths with more accuracy.

Patients with stable chest pain who were evaluated with coronary CT angiography (CTA) were significantly less likely to experience a heart attack or die from coronary heart disease (CHD) within five years compared to individuals who received standard testing, researchers reported in the New England Journal of Medicine.

The British Heart Foundation announced at this year’s ESC (European Society of Cardiology) Congress it’s launching the Big Beat Challenge, a research award that will throw £30 million—nearly $40 million—behind an innovation that could change the future of cardiovascular medicine.